EMBARC
LIVE

Serial Number

98258262

Owner

Instylla, Inc.

Attorney

William E. Anderson

Filing Date

Nov 7, 2023

Add to watchlist:

No watchlists yet
View on USPTO

EMBARC Trademark

Serial Number: 98258262

EMBARC is a trademark filed by Instylla, Inc. on November 7, 2023. The trademark is classified under Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus). The application is currently pending registration.

Owner Contact Info

Instylla, Inc. (8 trademarks)

Bedford, MA 01730

Entity Type: 03

Trademark Details

Filing Date

November 7, 2023

Registration Date

Not Registered

Published for Opposition

October 29, 2024

Goods & Services

Medical apparatus and instruments for embolization surgery; embolic devices for treating anomalies vasculature of the body; medical device, namely, vascular embolization device; medical device for embolization therapy in interventional radiology and oncology; embolic devices for interventional radiology, namely, interventional oncology and peripheral hemostasis; differentiated particle embolics for embolization surgery; medical device used for vascular embolization procedures; medical device and surgical instrument for use in organ ischemia or infarction interventions; medical device used for embolization of vascular lesions, tumors, targeted arterial segments of hypervascular tumors, control of bleeding due to disease or trauma, organs and segmental embolizations, or occlusion of blood flow in the peripheral vasculature; medical devices, namely, syringes and delivery catheters for the delivery of embolic agents delivered through a microcatheter under fluoroscopic control; kits for use in medical and surgical procedures comprised primarily of embolic particles; medical apparatus comprising a system for vascular embolization procedures in the nature of catheters for use in embolization procedures; embolic devices and kits comprising syringes, pouches, and caps for vascular embolization and peripheral hemostasis namely, an embolization therapy system, featuring embolic particles.

Pharmaceutical preparations, formulations, and suspensions for embolization therapy in interventional radiology and oncology in the nature of implantable materials comprised of living tissue, namely, embolic agents; pharmaceutical preparations for embolization therapy in the nature of implants comprised of living tissue, namely, embolic agents; pharmaceutical preparations, namely, embolization therapy preparations for embolization of tumors.

Filing History

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Dec 10, 2025 EXRA
SOU EXTENSION 2 GRANTED
Dec 9, 2025 EX2G
SOU EXTENSION 2 FILED
Dec 9, 2025 EXT2
SOU TEAS EXTENSION RECEIVED
Dec 9, 2025 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Sep 15, 2025 EXRA
SOU EXTENSION 1 GRANTED
May 28, 2025 EX1G
SOU EXTENSION 1 FILED
May 28, 2025 EXT1
SOU TEAS EXTENSION RECEIVED
May 28, 2025 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Dec 10, 2024 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Oct 29, 2024 NPUB
PUBLISHED FOR OPPOSITION
Oct 29, 2024 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Oct 9, 2024 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Sep 18, 2024 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 17, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 17, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sep 17, 2024 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jun 17, 2024 GNRN
NON-FINAL ACTION E-MAILED
Jun 17, 2024 GNRT
NON-FINAL ACTION WRITTEN
Jun 17, 2024 CNRT
ASSIGNED TO EXAMINER
Jun 15, 2024 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Dec 5, 2023 NWOS
NEW APPLICATION ENTERED
Nov 10, 2023 NWAP